Stay updated with breaking news from Path Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UiPath (NYSE:PATH – Get Free Report) was downgraded by research analysts at William Blair from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Thursday, Marketbeat.com reports. Other equities analysts have also issued research reports about the stock. Barclays upped their price objective on shares of […]
UiPath (NYSE:PATH – Get Free Report) was downgraded by analysts at William Blair from an “outperform” rating to a “market perform” rating in a research report issued on Thursday, MarketBeat reports. A number of other analysts have also recently issued reports on the company. Barclays lifted their price objective on UiPath from $23.00 to $25.00 […]
UiPath (NYSE:PATH – Get Free Report)‘s stock had its “hold” rating reaffirmed by Truist Financial in a report issued on Thursday, MarketBeat.com reports. They presently have a $14.00 target price on the healthcare company’s stock, down from their previous target price of $32.00. Truist Financial’s target price would indicate a potential upside of 14.19% from […]
UiPath (NYSE:PATH – Get Free Report)‘s stock had its “hold” rating reaffirmed by investment analysts at Needham & Company LLC in a report issued on Thursday, MarketBeat Ratings reports. Other research analysts have also recently issued research reports about the company. JPMorgan Chase & Co. raised UiPath from a “neutral” rating to an “overweight” rating […]
DnB Asset Management AS reduced its position in UiPath Inc. (NYSE:PATH – Free Report) by 9.6% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 105,998 shares of the healthcare company’s stock after selling 11,311 shares during the period. DnB Asset Management AS’s holdings in UiPath were worth […]